According to WuXi Biologics's latest financial reports the company's current revenue (TTM) is ₹185.72 B. In 2022 the company made a revenue of ₹185.72 B an increase over the revenue in the year 2021 that were of ₹135.47 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.